173 related articles for article (PubMed ID: 10064737)
1. Multiple dysfunctions of two apolipoprotein A-I variants, apoA-I(R160L)Oslo and apoA-I(P165R), that are associated with hypoalphalipoproteinemia in heterozygous carriers.
Daum U; Leren TP; Langer C; Chirazi A; Cullen P; Pritchard PH; Assmann G; von Eckardstein A
J Lipid Res; 1999 Mar; 40(3):486-94. PubMed ID: 10064737
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein A-I (R151C)Paris is defective in activation of lecithin: cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol efflux.
Daum U; Langer C; Duverger N; Emmanuel F; Benoit P; Denèfle P; Chirazi A; Cullen P; Pritchard PH; Bruckert E; Assmann G; von Eckardstein A
J Mol Med (Berl); 1999 Aug; 77(8):614-22. PubMed ID: 10543393
[TBL] [Abstract][Full Text] [Related]
3. Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements.
Cho KH; Durbin DM; Jonas A
J Lipid Res; 2001 Mar; 42(3):379-89. PubMed ID: 11254750
[TBL] [Abstract][Full Text] [Related]
4. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
[TBL] [Abstract][Full Text] [Related]
5. Interaction of reconstituted high density lipoprotein discs containing human apolipoprotein A-I (ApoA-I) variants with murine adipocytes and macrophages. Evidence for reduced cholesterol efflux promotion by apoA-I(Pro165-->Arg).
von Eckardstein A; Castro G; Wybranska I; Theret N; Duchateau P; Duverger N; Fruchart JC; Ailhaud G; Assmann G
J Biol Chem; 1993 Feb; 268(4):2616-22. PubMed ID: 8428938
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts.
Miettinen HE; Jauhiainen M; Gylling H; Ehnholm S; Palomäki A; Miettinen TA; Kontula K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3021-32. PubMed ID: 9409289
[TBL] [Abstract][Full Text] [Related]
7. The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein.
Laccotripe M; Makrides SC; Jonas A; Zannis VI
J Biol Chem; 1997 Jul; 272(28):17511-22. PubMed ID: 9211897
[TBL] [Abstract][Full Text] [Related]
8. ApoA-I(MALLORCA) impairs LCAT activation and induces dominant familial hypoalphalipoproteinemia.
Martín-Campos JM; Julve J; Escolà JC; Ordóñez-Llanos J; Gómez J; Binimelis J; González-Sastre F; Blanco-Vaca F
J Lipid Res; 2002 Jan; 43(1):115-23. PubMed ID: 11792730
[TBL] [Abstract][Full Text] [Related]
9. A natural apolipoprotein A-I variant, apoA-I (L141R)Pisa, interferes with the formation of alpha-high density lipoproteins (HDL) but not with the formation of pre beta 1-HDL and influences efflux of cholesterol into plasma.
Miccoli R; Zhu Y; Daum U; Wessling J; Huang Y; Navalesi R; Assmann G; von Eckardstein A
J Lipid Res; 1997 Jun; 38(6):1242-53. PubMed ID: 9215551
[TBL] [Abstract][Full Text] [Related]
10. Lecithin:cholesterol acyltransferase reaction on cellular lipid released by free apolipoprotein-mediated efflux.
Czarnecka H; Yokoyama S
Biochemistry; 1995 Apr; 34(13):4385-92. PubMed ID: 7703252
[TBL] [Abstract][Full Text] [Related]
11. Oxidation of methionine residues to methionine sulfoxides does not decrease potential antiatherogenic properties of apolipoprotein A-I.
Panzenböck U; Kritharides L; Raftery M; Rye KA; Stocker R
J Biol Chem; 2000 Jun; 275(26):19536-44. PubMed ID: 10751387
[TBL] [Abstract][Full Text] [Related]
12. Lipid-free apolipoproteins A-I and A-II promote remodeling of reconstituted high density lipoproteins and alter their reactivity with lecithin:cholesterol acyltransferase.
Durbin DM; Jonas A
J Lipid Res; 1999 Dec; 40(12):2293-302. PubMed ID: 10588955
[TBL] [Abstract][Full Text] [Related]
13. Recombinant proapoA-I(Lys107del) shows impaired lipid binding associated with reduced binding to plasma high density lipoprotein.
Huang W; Matsunaga A; Li W; Han H; Hoang A; Kugi M; Koga T; Sviridov D; Fidge N; Sasaki J
Atherosclerosis; 2001 Nov; 159(1):85-91. PubMed ID: 11689210
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of free apolipoprotein-mediated cellular lipid efflux by probucol.
Tsujita M; Yokoyama S
Biochemistry; 1996 Oct; 35(40):13011-20. PubMed ID: 8855936
[TBL] [Abstract][Full Text] [Related]
15. Effect of the surface lipid composition of reconstituted LPA-I on apolipoprotein A-I structure and lecithin: cholesterol acyltransferase activity.
Sparks DL; Frank PG; Neville TA
Biochim Biophys Acta; 1998 Feb; 1390(2):160-72. PubMed ID: 9507105
[TBL] [Abstract][Full Text] [Related]
16. Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I.
Leren TP; Bakken KS; Daum U; Ose L; Berg K; Assmann G; von Eckardstein A
J Lipid Res; 1997 Jan; 38(1):121-31. PubMed ID: 9034206
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional properties of reconstituted high density lipoprotein discs prepared with six apolipoprotein A-I variants.
Jonas A; von Eckardstein A; Kézdy KE; Steinmetz A; Assmann G
J Lipid Res; 1991 Jan; 32(1):97-106. PubMed ID: 1901346
[TBL] [Abstract][Full Text] [Related]
18. Site-directed mutagenesis and structure-function analysis of the human apolipoprotein A-I. Relation between lecithin-cholesterol acyltransferase activation and lipid binding.
Minnich A; Collet X; Roghani A; Cladaras C; Hamilton RL; Fielding CJ; Zannis VI
J Biol Chem; 1992 Aug; 267(23):16553-60. PubMed ID: 1644835
[TBL] [Abstract][Full Text] [Related]
19. Remodelling of reconstituted high density lipoproteins by lecithin: cholesterol acyltransferase.
Liang HQ; Rye KA; Barter PJ
J Lipid Res; 1996 Sep; 37(9):1962-70. PubMed ID: 8895062
[TBL] [Abstract][Full Text] [Related]
20. The N-terminal globular domain and the first class A amphipathic helix of apolipoprotein A-I are important for lecithin:cholesterol acyltransferase activation and the maturation of high density lipoprotein in vivo.
Scott BR; McManus DC; Franklin V; McKenzie AG; Neville T; Sparks DL; Marcel YL
J Biol Chem; 2001 Dec; 276(52):48716-24. PubMed ID: 11602583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
